James Song, MD

James Song, MD, chief medical officer and director of clinical research, Frontier Dermatology.

Articles by James Song, MD

Improving Remote Dermatology Care, Diagnosis, and Clinical Trial Diversity: James Song, MD

March 27th 2026

James Song, MD, discusses the direction teledermatology is heading and how more inclusive clinical trials can improve outcomes for patients of color.

Important Emerging Oral Therapies, Guidelines to Be Highlighted at AAD 2026: James Song, MD

ByPearl Steinzor,James Song, MD

March 20th 2026

James Song, MD, previews new oral therapies and guidelines psoriasis, atopic dermatitis, and chronic spontaneous urticaria.

Experts Highlight the Value of Detailed Clinical Discussions at Maui Derm 2026

ByPearl Steinzor,James Song, MD,Jerry Shapiro, MD,Donna Culton, MD,Philip J. Mease, MD

February 3rd 2026

Experts at Maui Derm 2026 discuss the meeting’s focus on in-depth clinical education, practical patient care pearls, and interdisciplinary networking.

Therapy-Guiding Measures, Treatment Options, and Decision-Making Strategies in Psoriasis: James Song, MD

ByPearl Steinzor,James Song, MD

January 26th 2026

James Song, MD, discusses best practices and strategies for managing patients with psoriasis in 2026.

James Song, MD

Articles by James Song, MD

Improving Remote Dermatology Care, Diagnosis, and Clinical Trial Diversity: James Song, MD

Important Emerging Oral Therapies, Guidelines to Be Highlighted at AAD 2026: James Song, MD

Experts Highlight the Value of Detailed Clinical Discussions at Maui Derm 2026

Therapy-Guiding Measures, Treatment Options, and Decision-Making Strategies in Psoriasis: James Song, MD

Latest Updated Articles

Trending on AJMC

FDA Approves First Oral Carbapenem Antibiotic for Complicated UTIs

Fourteen Years of HIV PrEP: How New Innovations Build on Decades of Progress in HIV

Oral COVID-19 PEP May Benefit High-Risk Groups More Than General Public: Peter J. Hotez, MD

Study Finds Flaw in Method for Key Oncology Value-Based Care Model

Ontada Analysis Finds GLP-1 RA Use Linked to Improved Survival in Patients With Cancer